THEMISMED — Themis Medicare Income Statement
0.000.00%
- IN₹11.49bn
- IN₹12.13bn
- IN₹4.06bn
- 95
- 16
- 15
- 36
Annual income statement for Themis Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,307 | 3,946 | 3,543 | 3,818 | 4,055 |
Cost of Revenue | |||||
Gross Profit | 1,435 | 2,261 | 2,194 | 2,268 | 2,735 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,897 | 3,085 | 2,974 | 3,425 | 3,664 |
Operating Profit | 409 | 862 | 570 | 393 | 391 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 413 | 953 | 725 | 534 | 397 |
Provision for Income Taxes | |||||
Net Income After Taxes | 357 | 729 | 569 | 435 | 298 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 357 | 729 | 569 | 435 | 298 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 357 | 729 | 569 | 435 | 298 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.88 | 7.91 | 6.17 | 4.72 | 3.24 |
Dividends per Share |